V002-3623 Screening compound: N-(4-{2-[4-(2-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-1,3-thiazol-2-yl)-2-[1-phenyl-N-(propan-2-yl)formamido]acetamide

V002-3623 Screening compound: N-(4-{2-[4-(2-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-1,3-thiazol-2-yl)-2-[1-phenyl-N-(propan-2-yl)formamido]acetamide
V002-3623 Screening compound: N-(4-{2-[4-(2-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-1,3-thiazol-2-yl)-2-[1-phenyl-N-(propan-2-yl)formamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V002-3623
N-(4-{2-[4-(2-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-1,3-thiazol-2-yl)-2-[1-phenyl-N-(propan-2-yl)formamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V002-3623

Molecular Formula

C27H30FN5O3S (C27 H30 FN5 O3 S)

Compound Name

N-(4-{2-[4-(2-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-1,3-thiazol-2-yl)-2-[1-phenyl-N-(propan-2-yl)formamido]acetamide

IUPAC name

N-(4-{2-[4-(2-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-13-thiazol-2-yl)-2-[1-phenyl-N-(propan-2-yl)formamido]acetamide

SMILES

CC(C)N(CC(Nc1nc(CC(N(CC2)CCN2c(cccc2)c2F)=O)cs1)=O)C(c1ccccc1)=O

InChI

InChI=1S/C27H30FN5O3S/c1-19(2)33(26(36)20-8-4-3-5-9-20)17-24(34)30-27-29-21(18-37-27)16-25(35)32-14-12-31(13-15-32)23-11-7-6-10-22(23)28/h3-11,18-19H,12-17H2,1-2H3,(H,29,30,34)

InChI Key

JUCSFJIJVNXFRT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19770492

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

523.63

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.045

Distribution Coefficient, logD

4.043

Water Solubility, LogSw

-4.03

Polar Surface Area

68.965

Acid Dissociation Constant (pKa)

9.74

Base Dissociation Constant (pKb)

2.22

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

V002-3623 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V002-3623 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V002-3623?
Check Price and Availability of V002-3623, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V002-3623 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V002-3623
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V002-3623
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V002-3623 available by request